Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostate Cancer Metastatic × Lenograstim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 2 Breast Neoplasms 2 Prostate Cancer Metastatic 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1

Interventions

enzalutamide 4 cabazitaxel 4 Prednisone 4 XRP6258 2 Docetaxel 2 sipuleucel-T 1 rucaparib 1 olaparib 1 Zuclomiphene 1 Prednisolone 1 Lenograstim 1 LY3023414 1 Injections 1 Hematologic Tests 1 Granulocyte Colony-Stimulating Factor 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02961257 2022-05-12

CABASTY

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 3 Completed

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡